Carregando...
Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies
Extreme prematurity is the leading cause of death among children under 5 years of age. Currently, there is no treatment for bronchopulmonary dysplasia (BPD), the most common complication of extreme prematurity. Experimental studies in animal models of BPD suggest that mesenchymal stromal cells (MSCs...
Na minha lista:
| Publicado no: | Stem Cells Transl Med |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5702524/ https://ncbi.nlm.nih.gov/pubmed/29045045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.17-0126 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|